142 related articles for article (PubMed ID: 35808991)
1. Impact of the Affordable Care Act's Physician Payments Sunshine Act on branded statin prescribing.
Li J; Wu B; Flory J; Jung J
Health Serv Res; 2022 Oct; 57(5):1145-1153. PubMed ID: 35808991
[TBL] [Abstract][Full Text] [Related]
2. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
[TBL] [Abstract][Full Text] [Related]
3. Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia.
Wood SF; Podrasky J; McMonagle MA; Raveendran J; Bysshe T; Hogenmiller A; Fugh-Berman A
PLoS One; 2017; 12(10):e0186060. PubMed ID: 29069085
[TBL] [Abstract][Full Text] [Related]
4. Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs.
Perlis RH; Perlis CS
PLoS One; 2016; 11(5):e0155474. PubMed ID: 27183221
[TBL] [Abstract][Full Text] [Related]
5. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
[TBL] [Abstract][Full Text] [Related]
7. Physician characteristics, industry transfers, and pharmaceutical prescribing: Empirical evidence from medicare and the physician payment sunshine act.
Brunt CS
Health Serv Res; 2019 Jun; 54(3):636-649. PubMed ID: 30273976
[TBL] [Abstract][Full Text] [Related]
8. The Association between Industry Payments and Brand-Name Prescriptions in Otolaryngologists.
Morse E; Hanna J; Mehra S
Otolaryngol Head Neck Surg; 2019 Oct; 161(4):605-612. PubMed ID: 31547772
[TBL] [Abstract][Full Text] [Related]
9. The impact of reducing pharmaceutical industry payments on physician prescribing.
Parker-Lue S
Health Econ; 2020 Mar; 29(3):382-390. PubMed ID: 31930636
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the Sunshine Act: Transparency Regulation and Financial Conflicts in Health Care.
Saver RS
Am J Law Med; 2017 Nov; 43(4):303-343. PubMed ID: 29452562
[TBL] [Abstract][Full Text] [Related]
11. Industry Payments to Physicians and Prescriptions of Brand-Name Proton-Pump Inhibitors.
Morse E; Fujiwara RJT; Mehra S
Otolaryngol Head Neck Surg; 2019 Jan; 160(1):70-76. PubMed ID: 30325706
[TBL] [Abstract][Full Text] [Related]
12. Association Between Open Payments-Reported Industry Transfers of Value and Prostaglandin Analog Prescribing in the US.
Nguyen AM; Anderson KE; Anderson G; Johnson TV
JAMA Ophthalmol; 2022 Sep; 140(9):855-862. PubMed ID: 35900736
[TBL] [Abstract][Full Text] [Related]
13. Disclosure of industry payments to prescribers: industry payments might be a factor impacting generic drug prescribing.
Qian J; Hansen RA; Surry D; Howard J; Kiptanui Z; Harris I
Pharmacoepidemiol Drug Saf; 2017 Jul; 26(7):819-826. PubMed ID: 28485111
[TBL] [Abstract][Full Text] [Related]
14. Associations between pharmaceutical industry payments to physicians and prescription of PARP inhibitors in the United States.
Murayama A; Marshall DC
Gynecol Oncol; 2024 Feb; 181():83-90. PubMed ID: 38147713
[TBL] [Abstract][Full Text] [Related]
15. Industry-sponsored meal payments are associated with prescriptions and Medicare expenditures on brand-name colchicine in the United States.
Murayama A
Int J Rheum Dis; 2024 Jan; 27(1):e14962. PubMed ID: 37923570
[TBL] [Abstract][Full Text] [Related]
16. The Association of Industry Payments to Physicians with Prescription of Brand-Name Intranasal Corticosteroids.
Morse E; Fujiwara RJT; Mehra S
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):442-448. PubMed ID: 29865931
[TBL] [Abstract][Full Text] [Related]
17. Industry Financial Relationships in Neurosurgery in 2015: Analysis of the Sunshine Act Open Payments Database.
de Lotbiniere-Bassett MP; McDonald PJ
World Neurosurg; 2018 Jun; 114():e920-e925. PubMed ID: 29581013
[TBL] [Abstract][Full Text] [Related]
18. Orthopaedic Surgeons Receive the Most Industry Payments to Physicians but Large Disparities are Seen in Sunshine Act Data.
Samuel AM; Webb ML; Lukasiewicz AM; Bohl DD; Basques BA; Russo GS; Rathi VK; Grauer JN
Clin Orthop Relat Res; 2015 Oct; 473(10):3297-306. PubMed ID: 26088767
[TBL] [Abstract][Full Text] [Related]
19. Public Awareness of and Contact With Physicians Who Receive Industry Payments: A National Survey.
Pham-Kanter G; Mello MM; Lehmann LS; Campbell EG; Carpenter D
J Gen Intern Med; 2017 Jul; 32(7):767-774. PubMed ID: 28265803
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
